Evidence map›Paper›PMID 34731882›Full record

ArticleBlood advances2022

Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP.

Adrienn Teraz-Orosz, Magdalena Gierula, Anastasis Petri, David Jones, Renos Keniyopoullos, Patricia Badia Folgado, Salvatore Santamaria, James T B Crawley, David A Lane, Josefin Ahnström

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Factor V variants in bleeding and thrombosis.Research and practice in thrombosis and haemostasis · 2024
    Article
  5. Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress.Research and practice in thrombosis and haemostasis · 2022
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Adrienn Teraz-OroszCentre for Haematology, Imperial College London, London, UK.
Magdalena GierulaCentre for Haematology, Imperial College London, London, UK.
Anastasis PetriCentre for Haematology, Imperial College London, London, UK.
David JonesCentre for Haematology, Imperial College London, London, UK.ORCID 0000-0002-4789-203X
Renos KeniyopoullosCentre for Haematology, Imperial College London, London, UK.
Patricia Badia FolgadoCentre for Haematology, Imperial College London, London, UK.
Salvatore SantamariaCentre for Haematology, Imperial College London, London, UK.
James T B CrawleyCentre for Haematology, Imperial College London, London, UK.ORCID 0000-0002-6723-7841
David A LaneCentre for Haematology, Imperial College London, London, UK.
Josefin AhnströmCentre for Haematology, Imperial College London, London, UK.ORCID 0000-0001-5313-6508
Imperial College London · GB

Funding

British Heart Foundation PG/14/37/30855British Heart Foundation PG/18/15/33566British Heart Foundation PG/20/13/34994British Heart Foundation RG/18/3/33405
6 · The paper itself

Abstract

Protein S is a cofactor in the tissue factor pathway inhibitor (TFPI) anticoagulant pathway. It enhances TFPIα-mediated inhibition of factor (F)Xa activity and generation. The enhancement is dependent on a TFPIα-protein S interaction involving TFPIα Kunitz 3 and protein S laminin G-type (LG)-1. C4b binding protein (C4BP), which binds to protein S LG1, almost completely abolishes its TFPI cofactor function. However, neither the amino acids involved in TFPIα enhancement nor the mechanisms underlying the reduced TFPI cofactor function of C4BP-bound protein S are known. To screen for functionally important regions within protein S LG1, we generated 7 variants with inserted N-linked glycosylation attachment sites. Protein S D253T and Q427N/K429T displayed severely reduced TFPI cofactor function while showing normal activated protein C (APC) cofactor function and C4BP binding. Based on these results, we designed 4 protein S variants in which 4 to 6 surface-exposed charged residues were substituted for alanine. One variant, protein S K255A/E257A/D287A/R410A/K423A/E424A, exhibited either abolished or severely reduced TFPI cofactor function in plasma and FXa inhibition assays, both in the presence or absence of FV-short, but retained normal APC cofactor function and high-affinity C4BP binding. The C4BP β-chain was expressed to determine the mechanisms behind the reduced TFPI cofactor function of C4BP-bound protein S. Like C4BP-bound protein S, C4BP β-chain-bound protein S had severely reduced TFPI cofactor function. These results show that protein S Lys255, Glu257, Asp287, Arg410, Lys423, and Glu424 are critical for protein S-mediated enhancement of TFPIα and that binding of the C4BP β-chain blocks this function.

Indexed as

LamininProtein SComplement C4b-Binding ProteinFactor VLipoproteinsThrombinComplement C4b-Binding ProteinFactor VLamininlipoprotein-associated coagulation inhibitorLipoproteinsProtein SThrombin

Identifiers

PMID34731882
PMCPMC8791571
OpenAlexW3209822899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.